首页> 外文OA文献 >Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study
【2h】

Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study

机译:瑞士艾滋病毒队列研究:感染艾滋病毒的既往和目前注射吸毒者以及鸦片替代治疗方案中的人对抗逆转录病毒疗法的吸收和病毒学应答:

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES: The aim of the study was to investigate the influence of continued injecting drug use, enrolment in an opiate substitution treatment programme (OSTP), or cessation of injecting drug use on the uptake and course of antiretroviral therapy (ART). Design A prospective observational study of all participants in the Swiss HIV Cohort Study followed between 1997 and 2006 was carried out. METHODS: We distinguished four groups of former or current injecting drug users (IDUs): (i) abstinent former IDUs; (ii) persons in OSTPs without concomitant injecting drug use; (iii) persons in OSTPs with concomitant injecting drug use; (vi) current IDUs. These groups were compared with a group of patients who had never been IDUs. Factors related to ART uptake and virological endpoints were analysed using logistic generalized estimating equations. RESULTS: We followed 8660 participants for 48 477 person-years; 29.7% were in the IDU HIV transmission group. The likelihood of being on ART at biannual visits was lower among individuals in OSTPs with concomitant injecting drug use [odds ratio (OR) 0.79; 95% confidence interval (CI) 0.71-0.89] and current IDUs (OR 0.80; 95% CI 0.67-0.96), compared with those who had never been IDUs (reference), abstinent former IDUs (OR 1.13; 95% CI 1.02-1.25) and individuals in OSTPs without injecting drug use (OR 1.18; 95% CI 1.06-1.31). The likelihood of suppressed viral replication on ART was similar among those who had never been IDUs, abstinent former IDUs and individuals in an OSTP without injecting drug use, and lower among those in OSTPs with concomitant drug use (OR 0.82; 95% CI 0.72-0.93) and current IDUs (OR 0.81; 0.65-1.00). Adherence to ART was decreased among persons with continued injecting drug use, and correlated with virological outcome. CONCLUSIONS: Uptake of and virological response to ART were improved among abstinent former IDUs and persons in OSTPs without concomitant injecting drug use, compared with persons with continued injecting drug use.
机译:目的:本研究的目的是调查持续注射药物,加入阿片替代治疗方案(OSTP)或停止注射药物对抗逆转录病毒疗法(ART)吸收和进程的影响。设计对1997年至2006年之间进行的瑞士艾滋病毒队列研究的所有参与者进行了一项前瞻性观察研究。方法:我们区分了四组既往或当前的注射吸毒者(IDU): (ii)未同时注射毒品的OSTP人群; (iii)在OSTP中伴随注射毒品使用的人; (vi)当前的注射毒品使用者。将这些组与从未使用过IDU的一组患者进行比较。使用逻辑对数估计方程分析与ART摄取和病毒学终点有关的因素。结果:我们追踪了8660名参与者,研究了48477人年。 IDU HIV传播组中有29.7%。在OSTP患者中,伴随注射毒品使用的情况,每两年进行一次抗病毒治疗的可能性较低[比值比(OR)为0.79; 95%的置信区间(CI)0.71-0.89]和当前的IDU(OR 0.80; 95%CI 0.67-0.96),而从未使用过IDU(参考),戒酒的以前的IDU(OR 1.13; 95%CI 1.02- 1.25)和未注射毒品的OSTP患者(OR 1.18; 95%CI 1.06-1.31)。在从未使用过IDU,戒断前的IDU以及未注射毒品的OSTP中的个体中,ART受到病毒复制抑制的可能性相似,而在同时使用毒品的OSTP中,这些可能性较低(OR 0.82; 95%CI 0.72- 0.93)和当前的IDU(OR 0.81; 0.65-1.00)。持续注射药物的人对ART的依从性降低,并且与病毒学结果相关。结论:与持续注射吸毒者相比,戒酒的既往注射毒品使用者和未注射毒品的OSTP人群中ART的吸收和病毒学应答得到了改善。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号